These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 20018612)

  • 1. Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL.
    Sengupta D; Koblansky A; Gaines J; Brown T; West AP; Zhang D; Nishikawa T; Park SG; Roop RM; Ghosh S
    J Immunol; 2010 Jan; 184(2):956-64. PubMed ID: 20018612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry.
    Snyder GA; Deredge D; Waldhuber A; Fresquez T; Wilkins DZ; Smith PT; Durr S; Cirl C; Jiang J; Jennings W; Luchetti T; Snyder N; Sundberg EJ; Wintrode P; Miethke T; Xiao TS
    J Biol Chem; 2014 Jan; 289(2):669-79. PubMed ID: 24275656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of bacterial interference with TLR4 signaling by Brucella Toll/interleukin-1 receptor domain-containing protein TcpB.
    Alaidarous M; Ve T; Casey LW; Valkov E; Ericsson DJ; Ullah MO; Schembri MA; Mansell A; Sweet MJ; Kobe B
    J Biol Chem; 2014 Jan; 289(2):654-68. PubMed ID: 24265315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brucella TIR-like protein TcpB/Btp1 specifically targets the host adaptor protein MAL/TIRAP to promote infection.
    Li W; Ke Y; Wang Y; Yang M; Gao J; Zhan S; Xinying D; Huang L; Li W; Chen Z; Li J
    Biochem Biophys Res Commun; 2016 Aug; 477(3):509-14. PubMed ID: 27311859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scaffolding role of TcpB in disrupting TLR4-Mal interactions: Three to tango.
    Saqib U; Baig MS
    J Cell Biochem; 2019 Mar; 120(3):3455-3458. PubMed ID: 30242887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Brucella TIR-like protein TcpB interacts with the death domain of MyD88.
    Chaudhary A; Ganguly K; Cabantous S; Waldo GS; Micheva-Viteva SN; Nag K; Hlavacek WS; Tung CS
    Biochem Biophys Res Commun; 2012 Jan; 417(1):299-304. PubMed ID: 22155231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP.
    Radhakrishnan GK; Yu Q; Harms JS; Splitter GA
    J Biol Chem; 2009 Apr; 284(15):9892-8. PubMed ID: 19196716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.
    Verstak B; Nagpal K; Bottomley SP; Golenbock DT; Hertzog PJ; Mansell A
    J Biol Chem; 2009 Sep; 284(36):24192-203. PubMed ID: 19592497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of TLR4 signaling by Brucella TIR-containing protein TcpB-derived decoy peptides.
    Ke Y; Li W; Wang Y; Yang M; Guo J; Zhan S; Du X; Wang Z; Yang M; Li J; Li W; Chen Z
    Int J Med Microbiol; 2016 Sep; 306(6):391-400. PubMed ID: 27289452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction.
    Gray P; Dunne A; Brikos C; Jefferies CA; Doyle SL; O'Neill LA
    J Biol Chem; 2006 Apr; 281(15):10489-95. PubMed ID: 16439361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of microtubule dynamics by a TIR domain protein from the intracellular pathogen Brucella melitensis.
    Radhakrishnan GK; Harms JS; Splitter GA
    Biochem J; 2011 Oct; 439(1):79-83. PubMed ID: 21692747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The
    Jakka P; Namani S; Murugan S; Rai N; Radhakrishnan G
    J Biol Chem; 2017 Dec; 292(50):20613-20627. PubMed ID: 29061850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling.
    Nagpal K; Plantinga TS; Wong J; Monks BG; Gay NJ; Netea MG; Fitzgerald KA; Golenbock DT
    J Biol Chem; 2009 Sep; 284(38):25742-8. PubMed ID: 19509286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-1 targets the TLR adaptor Mal at a crucial TIR-domain interaction site.
    Ulrichts P; Bovijn C; Lievens S; Beyaert R; Tavernier J; Peelman F
    J Cell Sci; 2010 Jan; 123(Pt 2):256-65. PubMed ID: 20048342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins.
    Cirl C; Wieser A; Yadav M; Duerr S; Schubert S; Fischer H; Stappert D; Wantia N; Rodriguez N; Wagner H; Svanborg C; Miethke T
    Nat Med; 2008 Apr; 14(4):399-406. PubMed ID: 18327267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
    Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
    J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
    Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
    Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HSV-1/TLR9-Mediated IFNβ and TNFα Induction Is Mal-Dependent in Macrophages.
    Zyzak J; Mitkiewicz M; Leszczyńska E; Reniewicz P; Moynagh PN; Siednienko J
    J Innate Immun; 2020; 12(5):387-398. PubMed ID: 31851971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.